For: | Park JM, Han NY, Han YM, Chung MK, Lee HK, Ko KH, Kim EH, Hahm KB. Predictive proteomic biomarkers for inflammatory bowel disease-associated cancer: Where are we now in the era of the next generation proteomics? World J Gastroenterol 2014; 20(37): 13466-13476 [PMID: 25309077 DOI: 10.3748/wjg.v20.i37.13466] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i37/13466.htm |
Number | Citing Articles |
1 |
Armin Schniers, Endre Anderssen, Christopher Graham Fenton, Rasmus Goll, Yvonne Pasing, Ruth Hracky Paulssen, Jon Florholmen, Terkel Hansen. The Proteome of Ulcerative Colitis in Colon Biopsies from Adults ‐ Optimized Sample Preparation and Comparison with Healthy Controls. PROTEOMICS – Clinical Applications 2017; 11(11-12) doi: 10.1002/prca.201700053
|
2 |
M.P.G. Barnett, L.R. Ferguson. Molecular Diagnostics. 2017; : 305 doi: 10.1016/B978-0-12-802971-8.00017-1
|
3 |
Sushil Sharma. The Charnolosome as a Novel Nanothereranostic Biomarker. 2025; : 335 doi: 10.1016/B978-0-443-21752-4.00032-8
|
4 |
Ji Hyun Back, So Yeon Kim, Man Bock Gu, Hyeon Ji Kim, Kyong-No Lee, Ji Eun Lee, Kyo Hoon Park. Proteomic analysis of plasma to identify novel biomarkers for intra-amniotic infection and/or inflammation in preterm premature rupture of membranes. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32884-y
|
5 |
Hagar Taman, Christopher G Fenton, Inga V Hensel, Endre Anderssen, Jon Florholmen, Ruth H Paulssen. Genome-wide DNA Methylation in Treatment-naïve Ulcerative Colitis. Journal of Crohn's and Colitis 2018; 12(11): 1338 doi: 10.1093/ecco-jcc/jjy117
|
6 |
Yingwei Wu, Karen Briley, Xiaofeng Tao. Nanoparticle‐based imaging of inflammatory bowel disease. WIREs Nanomedicine and Nanobiotechnology 2016; 8(2): 300 doi: 10.1002/wnan.1357
|
7 |
Marina Pierdominici, Angela Maselli, Barbara Varano, Cristiana Barbati, Paola Cesaro, Cristiano Spada, Angelo Zullo, Roberto Lorenzetti, Marco Rosati, Gabriella Rainaldi, Maria Rosaria Limiti, Luisa Guidi, Lucia Conti, Sandra Gessani. Linking estrogen receptor β expression with inflammatory bowel disease activity. Oncotarget 2015; 6(38): 40443 doi: 10.18632/oncotarget.6217
|